Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.
Journal: Diabetes care
Published: April 14, 2026
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status.
Journal: Kidney international reports
Published: March 25, 2026
Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.
Journal: medRxiv : the preprint server for health sciences
Published: March 13, 2026
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.
Journal: Diabetes, obesity & metabolism
Published: February 03, 2026
Association Between Off-Label Use of Cardio-Kidney-Metabolic Therapies and Risk of Cardiovascular Events in Type 1 Diabetes: A Real-World Evidence Study.
Journal: Diabetes, obesity & metabolism
Published: December 11, 2025
Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease.
Journal: Diabetes, obesity & metabolism
Published: December 07, 2025
Inflammation and Diabetic Kidney Disease.
Journal: International journal of molecular sciences
Published: December 01, 2025
Cumulative Effects of Vicadrostat and Empagliflozin on Albuminuria in CKD.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: May 13, 2025
Management of Diabetes in Patients with Chronic Kidney Disease.
Journal: Endocrine research
Published: March 22, 2025
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 21, 2025
Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 22, 2024
GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary.
Journal: Kidney international
Published: November 15, 2024
Last Updated: 09/26/2026